Literature DB >> 21343617

ER stress inhibits mTORC2 and Akt signaling through GSK-3β-mediated phosphorylation of rictor.

Chien-Hung Chen1, Tattym Shaikenov, Timothy R Peterson, Rakhan Aimbetov, Amangeldy K Bissenbaev, Szu-Wei Lee, Juan Wu, Hui-Kuan Lin, Dos D Sarbassov.   

Abstract

In response to environmental cues, cells coordinate a balance between anabolic and catabolic pathways. In eukaryotes, growth factors promote anabolic processes and stimulate cell growth, proliferation, and survival through activation of the phosphoinositide 3-kinase (PI3K)-Akt pathway. Akt-mediated phosphorylation of glycogen synthase kinase-3β (GSK-3β) inhibits its enzymatic activity, thereby stimulating glycogen synthesis. We show that GSK-3β itself inhibits Akt by controlling the mammalian target of rapamycin complex 2 (mTORC2), a key activating kinase for Akt. We found that during cellular stress, GSK-3β phosphorylated the mTORC2 component rictor at serine-1235, a modification that interfered with the binding of Akt to mTORC2. The inhibitory effect of GSK-3β on mTORC2-Akt signaling and cell proliferation was eliminated by blocking phosphorylation of rictor at serine-1235. Thus, in response to cellular stress, GSK-3β restrains mTORC2-Akt signaling by specifically phosphorylating rictor, thereby balancing the activities of GSK-3β and Akt, two opposing players in glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21343617     DOI: 10.1126/scisignal.2001731

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  69 in total

1.  O(2) regulates skeletal muscle progenitor differentiation through phosphatidylinositol 3-kinase/AKT signaling.

Authors:  Amar J Majmundar; Nicolas Skuli; Rickson C Mesquita; Meeri N Kim; Arjun G Yodh; Michelle Nguyen-McCarty; M Celeste Simon
Journal:  Mol Cell Biol       Date:  2011-10-17       Impact factor: 4.272

2.  ER stress: Autophagy induction, inhibition and selection.

Authors:  Harun-Or Rashid; Raj Kumar Yadav; Hyung-Ryong Kim; Han-Jung Chae
Journal:  Autophagy       Date:  2015-11-02       Impact factor: 16.016

3.  Defining the Domain Arrangement of the Mammalian Target of Rapamycin Complex Component Rictor Protein.

Authors:  Ping Zhou; Ning Zhang; Ruth Nussinov; Buyong Ma
Journal:  J Comput Biol       Date:  2015-07-15       Impact factor: 1.479

Review 4.  Role of the unfolded protein response in determining the fate of tumor cells and the promise of multi-targeted therapies.

Authors:  Kunyu Shen; David W Johnson; David A Vesey; Michael A McGuckin; Glenda C Gobe
Journal:  Cell Stress Chaperones       Date:  2017-09-27       Impact factor: 3.667

5.  Elovl5 regulates the mTORC2-Akt-FOXO1 pathway by controlling hepatic cis-vaccenic acid synthesis in diet-induced obese mice.

Authors:  Sasmita Tripathy; Donald B Jump
Journal:  J Lipid Res       Date:  2012-10-24       Impact factor: 5.922

Review 6.  mTOR complex 2 signaling and functions.

Authors:  Won Jun Oh; Estela Jacinto
Journal:  Cell Cycle       Date:  2011-07-15       Impact factor: 4.534

Review 7.  Mammalian TOR signaling to the AGC kinases.

Authors:  Bing Su; Estela Jacinto
Journal:  Crit Rev Biochem Mol Biol       Date:  2011-10-10       Impact factor: 8.250

Review 8.  Role of endoplasmic reticulum stress signalling in diabetic endothelial dysfunction and atherosclerosis.

Authors:  Yunzhou Dong; Conrad Fernandes; Yanjun Liu; Yong Wu; Hao Wu; Megan L Brophy; Lin Deng; Kai Song; Aiyun Wen; Scott Wong; Daoguang Yan; Rheal Towner; Hong Chen
Journal:  Diab Vasc Dis Res       Date:  2016-10-20       Impact factor: 3.291

9.  Overexpression of Rictor protein in colorectal cancer is correlated with tumor progression and prognosis.

Authors:  Lifeng Wang; Jia Qi; Jinlong Yu; Haijin Chen; Zhaowei Zou; Xiaohua Lin; Linlang Guo
Journal:  Oncol Lett       Date:  2017-09-14       Impact factor: 2.967

Review 10.  Insight into the role of mTOR and metabolism in T cells reveals new potential approaches to preventing graft rejection.

Authors:  Ying-Chun Lo; Chen-Fang Lee; Jonathan D Powell
Journal:  Curr Opin Organ Transplant       Date:  2014-08       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.